Bangkok Lab & Cosmetic PCL (BLC.BK) stock: key figures, P/E, revenue and dividend

Consumer Staples · Personal Care Products · Thailand

Price

3.92 THB

Market cap

2.35 bn THB

P/E (2025)

13.59

P/S (2025)

1.41

Dividend yield

6.12 %

Net margin

10.38 %

Return on equity (ROE)

10.43 %

Return on assets (ROA)

7.31 %

Bangkok Lab & Cosmetic PCL financials

Fiscal year	2024	2025
Revenue	1.56 bn THB	1.67 bn THB
Gross profit	872.19 m THB	977.26 m THB
Operating income	230.53 m THB	228.83 m THB
EBIT	230.53 m THB	228.83 m THB
Net income	171.35 m THB	173.02 m THB
Diluted EPS – continuing operations	0.29 THB	0.29 THB

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Bangkok Lab & Cosmetic PCL

Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and retail of modern medicines, dietary supplements, medical cosmetics, cosmetics, home remedies, herbal products, and medical devices; and the operation of direct marketing business. Bangkok Lab And Cosmetic Public Company Limited was founded in 1992 and is based in Ratchaburi, Thailand.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.